Intratumoral Pharmacokinetics: Challenges to Nanobiomaterials

Area of Science:

• Pharmacology
• Oncology
• Biomaterials Science

Background:

• Solid tumor resistance to cancer treatment is often due to pharmacokinetic challenges at cellular and multicellular levels.
• Anticancer agents require sufficient bioavailability at the tumor site for efficacy.
• Solid tumors typically exhibit poor blood perfusion, necessitating avascular drug penetration.

Purpose of the Study:

• To discuss recently proposed pharmacokinetic parameters for accurately assessing anticancer drug distribution within solid tumors.
• To present challenges associated with these new parameters for designing nanobiomaterial drug delivery systems.

Main Methods:

• Review and discussion of emerging pharmacokinetic parameters beyond traditional models.
• Analysis of drug penetration and distribution within the tumor microenvironment.
• Exploration of challenges in nanobiomaterial design based on new pharmacokinetic insights.

Main Results:

• Classic pharmacokinetic parameters are insufficient for characterizing intratumoral drug distribution due to perfusion discrepancies.
• New pharmacokinetic parameters offer a more accurate portrayal of drug behavior within solid tumors.
• These novel parameters present unique challenges for developing effective nanobiomaterial drug delivery systems.

Conclusions:

• Accurate pharmacokinetic assessment is crucial for overcoming solid tumor treatment resistance.
• Emerging pharmacokinetic parameters are vital for understanding and improving anticancer drug delivery.
• Addressing challenges posed by new pharmacokinetic parameters is key for advancing nanobiomaterial-based cancer therapies.